TABLE 3.

Molecular Distribution of Radiolabel in Tumors 2 Hours After Intravenous Injection of FU

Injected radiotracerPretreatment with EUn% activity recovery during HPLC% recovered activity
FFBAL + FUPA + FUH2FUFUrd ±  FdUrdFUMP ± FdUMPFUDP ± FdUDPFUTP ± FdUTPAIFUnidentified peaks
[18F]FUNo363 ± 35 ± 541 ± 53 ± 29 ± 710 ± 49 ± 111 ± 46 ± 26 ± 3
[3H]FUNo281*72 ± 111 ± 01 ± 017 ± 141 ± 03 ± 05 ± 11 ± 1
[18F]FUYes684 ± 4ND1 ± 046 ± 45 ± 112 ± 210 ± 111 ± 314 ± 11 ± 1
[3H]FUYes281 ± 24 ± 024 ± 54 ± 112 ± 214 ± 422 ± 617 ± 54 ± 1
  • * Measurable for only 1 of 2 experiments.

  • Data may include contribution from β-alanine.

  • P < 0.01 relative to unmodulated [18F]FU.

  • Data are presented as mean ± SEM. EU = eniluracil; F = fluoride ion; FBAL = α-fluoro-β-alanine; FUPA = α-fluoro-β-ureido-propanoic acid; FUH2 = dihydrofluorouracil; FUrd = fluorouridine; FdUrd = fluorodeoxyuridine; FUMP, FUDP, and FUTP, fluorouridine mono-, di-, and triphosphate, respectively; FdUMP, FdUDP, and FdUTP = fluorodeoxyuridine mono-, di-, and triphosphate, respectively; AIF = acid-insoluble fraction; ND = not detectable.